|
|
||||||||
The Journal of Immunology, Vol 158, Issue 1 187-199, Copyright © 1997 by American Association of Immunologists
ARTICLES |
NT Takaesu, JA Lower, D Yelon, EJ Robertson and EK Bikoff
Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA.
We used a "hit and run" gene targeting strategy to generate mice expressing only the p41 isoform of the conserved invariant (Ii) chain associated with MHC class II molecules. In contrast to mutants expressing only p31 Ii chain, a small proportion of A(alpha)b A(beta)b molecules produced by these animals have reduced mobilities in SDS-PAGE and appear incompletely processed. Nonetheless, class II surface expression, peptide occupancy, CD4+ T cell maturation, and proliferative responses toward intact protein Ags are efficiently reconstituted. Moreover, spleen cells exclusively expressing p41 or p31 alone display equivalent dose-response curves in Ag presentation assays. Similar conclusions were reached analyzing mutants expressing two independent MHC haplotypes. Overall, these results demonstrate that Ii chain functional activities as a class II-specific chaperone are largely shared by p31 and p41 isoforms in the intact animal. Mutant mouse strains producing only p31 or p41 under control of endogenous regulatory elements responsible for constitutive and inducible Ii chain expression should prove useful for dissecting the contributions of these isoforms to diverse CD4+ T cell responses in vivo, such as those responsible for Ab production, inflammatory responses, autoimmune diseases, and protection against infectious agents.
This article has been cited by other articles:
![]() |
C. H. Koonce and E. K. Bikoff Dissecting MHC Class II Export, B Cell Maturation, and DM Stability Defects in Invariant Chain Mutant Mice J. Immunol., September 1, 2004; 173(5): 3271 - 3280. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ye, P. W. Finn, R. Sweeney, E. K. Bikoff, and R. J. Riese MHC Class II-Associated Invariant Chain Isoforms Regulate Pulmonary Immune Responses J. Immunol., February 1, 2003; 170(3): 1473 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fiebiger, R. Maehr, J. Villadangos, E. Weber, A. Erickson, E. Bikoff, H. L. Ploegh, and A.-M. Lennon-Dumenil Invariant Chain Controls the Activity of Extracellular Cathepsin L J. Exp. Med., November 4, 2002; 196(9): 1263 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kenty and E. K. Bikoff BALB/c Invariant Chain Mutant Mice Display Relatively Efficient Maturation of CD4+ T Cells in the Periphery and Secondary Proliferative Responses Elicited upon Peptide Challenge J. Immunol., July 1, 1999; 163(1): 232 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Bikoff, G. Kenty, and L. Van Kaer Distinct Peptide Loading Pathways for MHC Class II Molecules Associated with Alternative Ii Chain Isoforms J. Immunol., April 1, 1998; 160(7): 3101 - 3110. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wang, P. A. Peterson, and L. Karlsson Decreased Endosomal Delivery of Major Histocompatibility Complex Class II-invariant Chain Complexes in Dynamin-deficient Cells J. Biol. Chem., July 4, 1997; 272(27): 17055 - 17060. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |